Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG)
Titel:
Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG)
Auteur:
Spieth, K. Kaufmann, R. Dummer, R. Garbe, C. Becker, J.C. Hauschild, A. Tilgen, W. Ugurel, S. Beyeler, M. Bröcker, E.B. Kaehler, K.C. Pföhler, C. Gille, J. Leiter, U. Schadendorf, D.